Indapta Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 30, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $22,500,000
Company Info
- Company Description
- Indapta Therapeutics is a privately held clinical stage biotechnology company developing next-generation cell therapies for the treatment of cancer and autoimmune diseases. The company focuses on developing and bringing to market a diverse pipeline of cell therapies to treat the still unmet medical needs of patients with blood and solid-tumor cancers as well as autoimmune diseases.
- Market
- Cancer and autoimmune diseases
- Location
- Houston, Texas, USA
- Coinvestors
- RA Capital Management, LP, Leaps by Bayer, Vertex Ventures HC, Pontifax, Myeloma Investment Fund